JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
|
CN |
|
D
|
Develia SA
WSE:DVL
|
PL |
|
C
|
Cian Agro Industries & Infrastructure Ltd
BSE:519477
|
IN |
|
B
|
Bhilwara Technical Textiles Ltd
BSE:533108
|
IN |
|
Prime Securities Ltd
NSE:PRIMESECU
|
IN |
|
United Rentals Inc
NYSE:URI
|
US |
|
L
|
LX Technology Group Ltd
HKEX:2436
|
CN |
|
I
|
Infomina Bhd
KLSE:INFOM
|
MY |
|
N
|
Nikkon Holdings Co Ltd
OTC:NIPKF
|
JP |
|
B
|
Bear Electric Appliance Co Ltd
SZSE:002959
|
CN |
|
B
|
Boundless Bio Inc
NASDAQ:BOLD
|
US |
|
Profilgruppen AB
STO:PROF B
|
SE |
|
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
CN |
|
Nissin Foods Co Ltd
HKEX:1475
|
HK |
Bankruptcy Probability
JiangXi Tianxin Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
JiangXi Tianxin Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
J
|
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
|
12B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
JiangXi Tianxin Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, JiangXi Tianxin Pharmaceutical Co Ltd has total debt of 345m CNY. This includes both short-term (0 CNY) and long-term (345m CNY) debt.
You can find a full breakdown on its Balance Sheet.